The Journal of Clinical and Preventive Cardiology has moved to a new website. You are currently visiting the old website of the journal. To access the latest content, please visit
Books and Trials

Recent Trials in Cardiology

Volume 2, Oct 2013

Vineet Bhatia MD, DM, Parneesh Arora MD, DM, Meetu Arora, MD, PGDCC, Nishith Chandra, MD, DM, New Delhi, India

Anticoagulation for 3 weeks before and 4 weeks postcardioversion for patients with atrial fibrillation (AF) has been the standard of care. AF of <48 hours (acute AF) duration has been traditionally cardioverted without anticoagulation cover. However, as the risk of embolization in this latter setting is real, recent guidelines recommend anticoagulation therapy during and after cardioversion in patients with acute AF and risk factors for stroke. The FinCV (Finnish CardioVersion) study was undertaken to answer these questions regarding anticoagulation in Acute AF.

Volume 2, Number 4, Pages: 214-5

Full text of this article: HTML  | PDF